Mengni N. Yi
Kongjiang Road 1665
Shanghai, 200092, China
Shanghai, 200092, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Zoledronic acid ameliorates multiple organ pathologies in a murine model of mucolipidosis II by partially restoring mannose-6-phosphate-mediated lysosomal hydrolase activities.
Journal: Molecular genetics and metabolism
Published: February 11, 2026
Identification of Cepharanthine as a Potential Therapy of Acid Sphingomyelinase Deficiency by Reducing Cellular Sphingosylphosphorylcholine.
Journal: Journal of inherited metabolic disease
Published: June 24, 2025
Central Nervous System-Targeted Gene Therapy for the Treatment of Neurocognitive Deficits in Mucopolysaccharidosis Type II Mice.
Journal: Human gene therapy
Published: February 27, 2025
Evaluation of the safety and efficacy of miglustat for the treatment of Chinese patients with Niemann-Pick disease type C: A prospective, open-label, single-arm, phase IV trial.
Journal: Intractable & rare diseases research
Published: November 01, 2024
Delayed diagnosis of mild mucopolysaccharidosis type IVA.
Journal: BMC medical genomics
Published: February 19, 2024
Clinical characteristics of 111 cases with mucopolysaccharidosis ⅣA
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: June 14, 2023
Investigation of GALNS variants and genotype-phenotype correlations in a large cohort of patients with mucopolysaccharidosis type IVA.
Journal: Journal of inherited metabolic disease
Published: August 31, 2021
Potential Disease-Modifying Effects of Lithium Carbonate in Niemann-Pick Disease, Type C1.
Journal: Frontiers in pharmacology
Published: February 19, 2021
Ambroxol improves skeletal and hematological manifestations on a child with Gaucher disease.
Journal: Journal of human genetics
Published: February 03, 2019
The potassium channel KCa3.1 constitutes a pharmacological target for astrogliosis associated with ischemia stroke.
Journal: Journal of neuroinflammation
Published: July 19, 2017
KCa3.1 Inhibition Switches the Astrocyte Phenotype during Astrogliosis Associated with Ischemic Stroke Via Endoplasmic Reticulum Stress and MAPK Signaling Pathways.
Journal: Frontiers in cellular neuroscience
Published: June 06, 2017
The Potassium Channel KCa3.1 Represents a Valid Pharmacological Target for Astrogliosis-Induced Neuronal Impairment in a Mouse Model of Alzheimer's Disease.
Journal: Frontiers in pharmacology
Published: October 17, 2016
Last Updated: 09/26/2026